We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+37.44%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$1.04B
AUM Growth
+$198M
Cap. Flow
+$14M
Cap. Flow %
1.35%
Top 10 Hldgs %
42.78%
Holding
150
New
56
Increased
28
Reduced
29
Closed
29

Top Buys

Rank Stock Value
1
ATRC icon
AtriCure
ATRC
+$12.9M
2
LHCG
LHC Group LLC
LHCG
+$9.74M
3
CNMD icon
CONMED
CNMD
+$7.65M
4
LIVN icon
LivaNova
LIVN
+$7.59M
5
IMVT icon
Immunovant
IMVT
+$5.8M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$5.47M
2
XLRN
Acceleron Pharma
XLRN
+$5.43M
3
STAA icon
STAAR Surgical
STAA
+$5.36M
4
QDEL icon
QuidelOrtho
QDEL
+$5.09M
5
ADPT icon
Adaptive Biotechnologies
ADPT
+$4.68M

Sector Composition

Rank Sector Weight
1 Healthcare 38.45%
2 Industrials 1.39%
3 Energy 1.11%
4 Consumer Discretionary 0.31%
5 Consumer Staples 0.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNTA
51
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$4.97M 0.48%
149,514
-96,700
-39% -$3.08M
COO icon
52
PUT
Cooper Companies
COO
$14.9B
$4.96M 0.48%
+70,000
New +$5.19M
MSON
53
DELISTED
Misonix Inc
MSON
$4.93M 0.47%
363,586
+43,586
+14% +$533K
LIVN icon
54
CALL
LivaNova
LIVN
$4.48B
$4.91M 0.47%
+102,000
New +$5.11M
TWST icon
55
Twist Bioscience
TWST
$7.84B
$4.9M 0.47%
108,181
-64,489
-37% -$2.31M
ABM icon
56
ABM Industries
ABM
$2.82B
$4.76M 0.46%
+131,200
New +$4.25M
EW icon
57
PUT
Edwards Lifesciences
EW
$53.5B
$4.63M 0.45%
+67,000
New +$4.76M
APYX icon
58
Apyx Medical
APYX
$128M
$4.58M 0.44%
825,117
+122,668
+17% +$510K
AVDL
59
DELISTED
Avadel Pharmaceuticals
AVDL
$4.55M 0.44%
562,800
+66,140
+13% +$583K
OTIC
60
DELISTED
Otonomy, Inc.
OTIC
$4.51M 0.43%
1,246,858
– –
NVTA
61
DELISTED
Invitae Corporation
NVTA
$4.27M 0.41%
+140,900
New +$2.46M
STXS icon
62
Stereotaxis
STXS
$137M
$4.02M 0.39%
902,275
-127,006
-12% -$514K
TXG icon
63
10x Genomics
TXG
$7.5B
$3.92M 0.38%
43,920
-10,700
-20% -$833K
KRMD icon
64
KORU Medical Systems
KRMD
$157M
$3.86M 0.37%
+429,916
New +$4.35M
CERS icon
65
Cerus
CERS
$538M
$3.74M 0.36%
566,321
-110,000
-16% -$631K
CPRX
66
DELISTED
Catalyst Pharmaceutical
CPRX
$3.65M 0.35%
789,603
-657,350
-45% -$2.95M
ABMD
67
PUT
DELISTED
Abiomed Inc
ABMD
$3.62M 0.35%
15,000
-70,700
-82% -$14.2M
IMMU
68
CALL
DELISTED
Immunomedics Inc
IMMU
$3.62M 0.35%
+102,000
New +$2.98M
MASI
69
PUT
DELISTED
Masimo
MASI
$3.42M 0.33%
+15,000
New +$3.29M
LAB icon
70
Standard BioTools
LAB
$308M
$3.39M 0.33%
+844,300
New +$2.94M
ITMR
71
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
$3.3M 0.32%
177,547
+24,600
+16% +$387K
NVCR icon
72
CALL
NovoCure
NVCR
$2.04B
$3.29M 0.32%
55,400
+1,000
+2% +$65.8K
CLDX icon
73
Celldex Therapeutics
CLDX
$3.49B
$3.25M 0.31%
+250,100
New +$1.11M
ADPT icon
74
Adaptive Biotechnologies
ADPT
$3.98B
$3.23M 0.31%
66,700
-128,300
-66% -$4.68M
TRS icon
75
TriMas Corp
TRS
$1.42B
$3.19M 0.31%
+133,000
New +$3.06M
1 2
3
4 5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q2 2020 Portfolio in Review

As of Q2 2020, Pura Vida Investments held 150 positions worth $1.04B, up 23% from $842M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Pura Vida Investments's Q2 2020 filing shows 56 new, 28 increased, 29 reduced and 29 closed positions. Its largest new stake was LHC Group LLC: 66,359 shares worth $11.6M. The largest sale was Regeneron Pharmaceuticals, an estimated $5.47M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 35% a quarter earlier, followed by Industrials and Energy.

  • Pura Vida Investments's largest Q2 2020 buy was LHC Group LLC: 66,359 shares worth $11.6M.
  • Pura Vida Investments added most to AtriCure in Q2 2020, an estimated $12.9M increase.
  • Pura Vida Investments's biggest Q2 2020 reduction was Acceleron Pharma, cutting an estimated $5.43M.
  • Pura Vida Investments fully exited Regeneron Pharmaceuticals in Q2 2020, selling an estimated $5.47M.
  • Pura Vida Investments's ten largest holdings make up 43% of its $1.04B portfolio in Q2 2020.
  • Pura Vida Investments opened 56 new positions and closed 29 in Q2 2020.
  • Pura Vida Investments's portfolio value rose 23% quarter-over-quarter to $1.04B.

Based on Pura Vida Investments's 13F filing for Q2 2020, filed 14 Aug 2020.